• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MBI taps Venkatadri as CEO

Article

Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and

Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and corporate development activities. Venkatadri's promotion culminated a succession plan agreed upon when he was hired in November 1995, according to the San Diego-based company.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.